Advertisement

Ads Placeholder
Loading...

Johnson & Johnson

JNJ•NYSE
Healthcare
Drug Manufacturers - General
$243.04
$-1.08(-0.44%)
U.S. Market opens in 3h 59m

Johnson & Johnson (JNJ) Stock Overview

Explore Johnson & Johnson’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap585.7B
P/E Ratio22.02
EPS (TTM)$11.03
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$227.93
3 Months$258.08
1 Year Target$179.28

JNJ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Johnson & Johnson (JNJ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.07, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $179.28.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.02 and a market capitalization of 585.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.44%
5-Day Change
0.77%
1-Month Change
-1.50%
3-Month Change
17.21%
6-Month Change
28.84%
Year-to-Date (YTD) Change
17.21%
1-Year Change
52.07%
3-Year Change
54.95%
5-Year Change
48.71%
All-Time (Max) Change
19821.31%

Contact Information

https://www.jnj.com
732 524 0400
One Johnson & Johnson Plaza, New Brunswick, NJ, 08933

Company Facts

1,381,000 Employees
IPO DateJan 2, 1943
CountryUS
Actively Trading

Frequently Asked Questions